David Carbone

David Carbone, MD, PHD

  • Medical Oncology
  • Physician

Professor of Internal Medicine

Accepting new patients
4.9 out of 5
  • 80 Patient Satisfaction Ratings
  • 12 Patient Comments

Insurances We Accept

614-293-6786

About Me

I am a medical oncologist who specializes in creating cutting-edge treatments for patients with lung cancer. This is a disease with unacceptable outcomes, but there are many promising therapies today and on the horizon. I was named to the Castle Connolly list of “America's Top Doctors” from 2004 to 2019 and rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016.

I serve as a professor of internal medicine at The Ohio State University and co-leader of the Translational Therapeutics Program at the OSUCCC – James, where I also direct the Thoracic Oncology Center. In addition, I am the president of the International Association for the Study of Lung Cancer (IASLC) and hold the Barbara J. Bonner Chair in Lung Cancer Research.

My research is focused specifically on proteomic and expression array signature development, genetics, immunotherapy and tumor-associated immunosuppression mechanisms in lung cancer. Some of my recent research directions include the development of molecular biomarkers to guide patient management and therapy, and molecular profiling of lung cancers and pre-neoplasias to guide the development of therapeutics, especially using mass spectrometry-based proteomics.

I’ve served as an investigator on multiple clinical trials, including the large phase III lung cancer trials, for the Eastern Cooperative Oncology Group (ECOG), one of the largest clinical cancer research organizations in the U.S. Additionally, I’ve authored more than 250 peer-reviewed publications, book chapters and articles. I have served on several National Cancer Institute (NCI) grant review panels and the NCI Board of Scientific Counselors. I am also a past president of the International Association for the Study of Lung Cancer and current co-chair of the NCI CTEP Thoracic Malignancies Steering Committee.

In 2012, I came to Ohio State from Vanderbilt University to establish and direct the OSUCCC – James thoracic center. With our multidisciplinary team approach, we apply advanced molecular diagnostics and state-of-the-art therapeutics to provide personalized care every lung cancer patient.

The collaborative spirit, team approach, dedicated patient care and enlightened leadership we enjoy at the OSUCCC – James all come together together to make this a great place to work and a great place to receive treatment for cancer.
Highlights
  • Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016, 2019
  • Named to the Castle Connolly list of “America's Top Doctors”; "America's Top Doctors for Cancer"; "Regional Top Doctors"
  • Best Doctor in America, 2017

Procedures and Conditions I Treat

  • Mesothelioma
  • Carcinoma, Non-Small-Cell Lung
  • Small Cell Lung Carcinoma
  • Lung Cancers

Locations Where I Practice

Please note: Not all physicians schedule patients at each listed location.

Education and Training

Education History

Graduate

Johns Hopkins University School of Medicine, Baltimore, MD
9/1/1977 - 5/31/1985

Medical School

Johns Hopkins University School of Medicine, Baltimore, MD
9/1/1977 - 5/31/1985

Internship

Johns Hopkins Bayview Medical Center, Baltimore, MD
7/1/1985 - 6/30/1986

Residency

Johns Hopkins Bayview Medical Center, Baltimore, MD
7/1/1986 - 6/30/1988

Fellowship

National Cancer Institute, NIH, Bethesda, MD
7/1/1988 - 6/30/1991

Board Certification

American Board of Internal Medicine
9/15/1988

Academic Information

My Department

Internal Medicine

My Division

Medical Oncology

More About My Work

Reviews

The overall patient satisfaction rating is an average of all patient responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page.

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of Ohio State Wexner Medical Center.

80 Patient Satisfaction Reviews

  • Overall
    4.9 out of 5
  • Kept you informed about your condition and treatment
    4.9 out of 5
  • Amount of time spent with you
    4.9 out of 5
  • Concern for your questions and issues
    4.9 out of 5
  • Skill and knowledge
    4.9 out of 5
  • Overall quality of care
    4.9 out of 5
  • Reviewed on Feb 10, 2024

    I have total trust in Dr. Carbone and his staff.

  • Reviewed on Nov 18, 2023

    Dr. Carbone is incredibly knowledgeable about the cancer that I have. He has helped me tremendously.I am worried about who will fill Dr. Carbone's shoes when he retires some day.

  • Reviewed on Jul 27, 2023

    We really appreciate Dr. Carbone and his staff. They are always there for you. God bless you all, we appreciate each and every one of you!

  • Reviewed on Jun 05, 2023

    Dr. Carbone is just the best. I really like and trust him. Dr. Carbone was very patient with my many questions, answered each with a thorough, clear explanation, and offered both reassurances and guidance where needed.

  • Reviewed on May 24, 2023

    Most excellent dr. Very much comfort with him.

  • Reviewed on May 23, 2023

    Dr. Carbone took his time and helped me understand why in his opinion he did not think I needed immunotherapy.

  • Reviewed on Apr 28, 2023

    Physician & physician asst. were well prepared with my case for a 1st visit to the James.

  • Reviewed on Apr 22, 2023

    Dr. Carbone was very nice & informing!

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 09/30/2022, Dr. Carbone has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

  • AstraZeneca
  • Merck & Co., Inc.
  • Novartis
  • Regeneron Pharmaceuticals
  • Mirati Therapeutics, Inc.
  • Bristol Myers Squibb
  • AbbVie

Subscribe. Get just the right amount of health and wellness in your inbox.